| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 06/23/2004 | EP1017404B1 Pharmaceutical composition for the treatment of inflammatory bowel disease |
| 06/23/2004 | EP0983251B1 Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof |
| 06/23/2004 | EP0966424B1 Aminobenzophenones as inhibitors of interleukin and tnf |
| 06/23/2004 | CN1507456A Fibre containing composition for enteral nutrition |
| 06/23/2004 | CN1507450A Novel cyclo azaphospha hydrocarbons |
| 06/23/2004 | CN1507449A 1-oxa-3,9-diaza-spiro [5,5] undecan-2-ones derivatives and its use as antagonist of the neurikinin receptor |
| 06/23/2004 | CN1507434A Novel 4-anilinoquinoline-3-carboxamides compound |
| 06/23/2004 | CN1507354A Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists |
| 06/23/2004 | CN1507348A Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders |
| 06/23/2004 | CN1507344A Method to obtain microparticles containing a H*, K*-ATP enzyme inhibitor |
| 06/23/2004 | CN1507343A Method to obtain microparticle containing a H*, K*-ATP-enzyme inhibitor |
| 06/23/2004 | CN1506364A Optically pure S-(-)-and R-(+)- Omeprazole prepn and the prepn process |
| 06/23/2004 | CN1506363A Photoactive dicyclic alcohol and its prepn, medicinal composition and use |
| 06/23/2004 | CN1506102A Toxin expelling and face nursing aloe capsule and its making process |
| 06/23/2004 | CN1506098A Medicine composition for treating liver fibrillation and liver cirrhosis and its prepn process |
| 06/23/2004 | CN1506094A Elsholizia extract granule for treating diarrhea and its prepn |
| 06/23/2004 | CN1506093A Elsholizia extract prepn and its quality control method and new use |
| 06/23/2004 | CN1506092A Elsholizia extract capsule for treating diarrhea and its prepn |
| 06/23/2004 | CN1506087A Fat-eliminating liver-protecting medicine capsule for treating hepatosis and its prepn |
| 06/23/2004 | CN1506085A Chinese goldthread soft capsule for clearing away adverse lung energy and its prepn process |
| 06/23/2004 | CN1506083A Gastrosis treating Chinese medicine powder and its usage |
| 06/23/2004 | CN1506077A Liver-protecting and blood fat-reducing product |
| 06/23/2004 | CN1506046A Active compound of Baojiwan pill for resisting diarrhea and reducing gastrointestinal illness |
| 06/23/2004 | CN1506043A Quickly disintegrating tablet containing cadotril |
| 06/23/2004 | CN1505981A Health food with effects of regulatnig blood fat and improving intestinal tract function |
| 06/23/2004 | CN1505980A Nutritious composition |
| 06/23/2004 | CN1505979A Nutritious composition |
| 06/23/2004 | CN1505978A Nutritious constituents |
| 06/23/2004 | CN1154655C K receptor opioid peptides |
| 06/23/2004 | CN1154646C Benzisozazoles and phenones as alpha antagonist |
| 06/23/2004 | CN1154635C Novel compounds with analgesic effect |
| 06/23/2004 | CN1154510C Preparation of directly mouldable tabletting auxiliary |
| 06/23/2004 | CN1154504C Lingguo extract capsule and its prepn. method |
| 06/23/2004 | CN1154503C Antimycotic antidiarrheal |
| 06/23/2004 | CN1154497C Method of treatment of lever tumours and pharmaceutical compositions for use therein |
| 06/23/2004 | CN1154490C Celecoxib compositions |
| 06/23/2004 | CN1154489C Heterocyclic vinylethers against neurological disorders |
| 06/23/2004 | CN1154471C Methods of reducing astringency of stannous in dentifrice compositions |
| 06/22/2004 | US6753340 Autoimmune disease, antiarthritic agents, antiallergens, anticancer agents |
| 06/22/2004 | US6753335 Delta agonists for nervous system pain |
| 06/22/2004 | US6753332 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 06/22/2004 | US6753325 Comprises vitamin d3 for controlling cell differentiation and/or cell proliferation |
| 06/22/2004 | CA2122022C Anti-explosion pads and their method of use |
| 06/17/2004 | WO2004050656A1 1,3-dihydroimidazole fused-ring compound |
| 06/17/2004 | WO2004050118A1 Cysteine protease inhibitor |
| 06/17/2004 | WO2004050116A1 Protease inhibitor |
| 06/17/2004 | WO2004050114A1 Novel agent for improving neurotransmission failure |
| 06/17/2004 | WO2004050086A1 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics |
| 06/17/2004 | WO2004049964A2 Drug to be introduced tooth or periodontal tissue and apparatus for introducing drug to tooth or periodontal tissue |
| 06/17/2004 | WO2004028460A3 Prebiotic and preservative uses of oil-emulsified probiotic encapsulations |
| 06/17/2004 | WO2004012651A3 Composition for heart disease, method to prepare same and uses thereof |
| 06/17/2004 | WO2004003164A3 Methods of organ regeneration |
| 06/17/2004 | WO2003106660A3 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/17/2004 | WO2003105781A3 Ophthalmic compositions for treating ocular hypertension |
| 06/17/2004 | WO2003099110A3 Herbs and herbal combinations useful for the treatment of microbial infections |
| 06/17/2004 | WO2003070184A3 Sodium channel blockers |
| 06/17/2004 | WO2003053997A3 Methods of increasing endogenous erythropoietin (epo) |
| 06/17/2004 | WO2003053334A3 Compositions and methods for the diagnosis and treatment of tumor |
| 06/17/2004 | US20040116708 Carboxylic acids |
| 06/17/2004 | US20040116706 Therapeutic ureas |
| 06/17/2004 | US20040116703 Central nervous system disorders, nicotinic acetylcholine receptors; endocrine diseases; antiinflammatory agents; analgesics; drug dependency; skin disorders; Alzheimer's and Parkinson's disease |
| 06/17/2004 | US20040116698 6-Substituted pyrido-pyrimidines |
| 06/17/2004 | US20040116697 Novel compounds |
| 06/17/2004 | US20040116695 2-Mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors |
| 06/17/2004 | US20040116652 Method for producing and using novel human defensins as biologically active proteins for treating infections and other diseases |
| 06/17/2004 | US20040116530 Tissue fibrosis inhibitors |
| 06/17/2004 | US20040116527 Agents against stress-induced diseases |
| 06/17/2004 | US20040116520 Anti-stress agents |
| 06/17/2004 | US20040116516 Pharmaceutical composition |
| 06/17/2004 | US20040116509 Antiviral agent; reducing the activity of viral polymerase; 3-(4-Chloro-2,5-dimethyl-benzenesulfonylamino)-5-(4-chloro-phenyl)-thiophene-2-carboxylic acid for example |
| 06/17/2004 | US20040116493 Anti-helicobacterial agents |
| 06/17/2004 | US20040116486 Metalloproteinase inhibitors |
| 06/17/2004 | US20040116472 inhibit angiogenesis, tumor metastasis and growth, osteoporosis, Paget's disease, hypercalcemia of malignancy, retinopathy, macular degeneration, arthritis, periodontal disease, smooth muscle cell migration and viral diseases |
| 06/17/2004 | US20040116458 Chemical compounds |
| 06/17/2004 | US20040116454 Pyrazole compounds useful as protein kinase inhibitors |
| 06/17/2004 | US20040116445 Substituted thioacetamides |
| 06/17/2004 | US20040116440 Useful for diagnosis, treatment of male or female sexual dysfunction |
| 06/17/2004 | US20040116439 Serine protease inhibitors |
| 06/17/2004 | US20040116438 Compositions for treatment of cell proliferation disorders |
| 06/17/2004 | US20040116431 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 06/17/2004 | US20040116426 Small molecules useful in the treatment of inflammatory disease |
| 06/17/2004 | US20040116424 Aryl imidazoles and related compounds as C5a receptor modulators |
| 06/17/2004 | US20040116423 5-Aryltetrazole compounds, compositions thereof, and uses therefor |
| 06/17/2004 | US20040116416 having immunomodulating and cytokine-release-inhibiting action |
| 06/17/2004 | US20040116405 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity |
| 06/17/2004 | US20040116395 Combinations for the treatment of inflammatory disorders |
| 06/17/2004 | US20040116387 thyroid receptor ligands, preferably antagonists for the treatment of cardiac and metabolic disorders, such as cardiac arrhythmias, thyrotoxicosis, subcllinical hyperthyrodism and liver diseases |
| 06/17/2004 | US20040116383 has no toxicity, and have a unique curative effect, without influence on the trip and living, so that it can be used widely for a long period |
| 06/17/2004 | US20040116355 Caspase inhibitors and the use thereof |
| 06/17/2004 | US20040116353 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 06/17/2004 | US20040116342 Therapeutic use of a SMR1-peptide or a pharmaceutically active amount of SMR1-peptide, for the preparation of a therapeutic formulation for preventing or treating diseases wherein a modulation of activity of a membrane metallopeptidase is sought |
| 06/17/2004 | US20040116336 Peptide derivatives |
| 06/17/2004 | US20040116328 Condensed imidazole derivatives |
| 06/17/2004 | US20040115808 In vitro neuronal stem cell culture for transplantation and treatment of neurodegenerative and gastrointestinal diseases; tissue engineering |
| 06/17/2004 | US20040115773 Serpin in bifidobacteria |
| 06/17/2004 | US20040115619 Immunoglobulin which binds hepatitis c viral envelope proteins and prevents and treats viral diseases; immunotherapy; viricides |
| 06/17/2004 | US20040115282 May be administered for preparing the colon for surgical or diagnostic procedures or childbirth |
| 06/17/2004 | US20040115243 Compositions for oral delivery of nutrients and pharmaceuticals |
| 06/17/2004 | US20040115181 Composition for transmucosal adminstration containing conenzyme q as the active ingredient |
| 06/17/2004 | US20040115179 treating and preventing gastrointestinal diseases as well as lowering serum cholesterol |